DJ Biogen Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ rose 3.22% to $189.94 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.78% to 6,869.50 and the Dow Jones Industrial Average rising 0.49% to 48,739.41.
The stock's rise snapped a two-day losing streak.
Biogen Inc. closed 6.16% short of its 52-week high of $202.41, which the company achieved on February 6th.
The stock outperformed some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ fell 0.59% to $245.30, Pfizer Inc. $(PFE)$ rose 0.15% to $26.62, and AbbVie Inc. $(ABBV)$ rose 1.00% to $236.19.
Trading volume (952,475) remained 749,175 below its 50-day average volume of 1.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 4, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 04, 2026 17:03 ET (22:03 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments